Publications in collaboration with researchers from King's College London (42)

2024

  1. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets

    Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106

  2. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

    Seminars in Arthritis and Rheumatism, Vol. 65

2023

  1. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

    Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 6, pp. 100147

  2. Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 984-995

2022

  1. What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?

    Expert Review of Clinical Immunology

2021

  1. Clinical presentation of antiphospholipid syndrome

    Lahita’s Systemic Lupus Erythematosus (Elsevier), pp. 561-574

2020

  1. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 72, Núm. 1, pp. 67-77

  2. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis and Rheumatology, Vol. 72, Núm. 4, pp. 658-666

2018

  1. Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

    Arthritis Care and Research, Vol. 70, Núm. 1, pp. 98-103

2017

  1. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: Results of an international multicentre study

    Lupus, Vol. 26, Núm. 3, pp. 266-276

  2. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study

    Arthritis Research and Therapy, Vol. 19, Núm. 1

  3. Treatment of Thrombosis in Antiphospholipid Syndrome

    Handbook of Systemic Autoimmune Diseases (Elsevier Ltd), pp. 231-241

2016

  1. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 5, pp. 795-810

  2. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies: Evidence and clinical judgment

    Thrombosis and Haemostasis, Vol. 115, Núm. 2, pp. 285-290

2015

  1. Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study

    Arthritis and Rheumatology, Vol. 67, Núm. 7, pp. 1837-1847

2014

  1. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: A prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 275-284

  2. Prednisone in lupus nephritis: How much is enough?

    Autoimmunity Reviews, Vol. 13, Núm. 2, pp. 206-214

2013

  1. Belimumab en el lupus eritematoso sistémico: una guía para su uso en la práctica diaria

    Revista Clinica Espanola

  2. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 8, pp. 1308-1314

  3. Headache in systemic lupus erythematosus: Results from a prospective, international inception cohort study

    Arthritis and Rheumatism, Vol. 65, Núm. 11, pp. 2887-2897